• Polyamine metabolism is dysregulated in tumors, offering novel targets for cancer therapy.
• Inhibiting polyamine biosynthesis and transport systems are promising antitumor strategies.
• Polyamines regulate cancer signaling pathways, supporting combination therapies.
• Supplemental polyamines show antitumor activity, suggesting benefits when combined with immunotherapy.